Common medicine offers hope for fatal childhood brain disease
A recent study from the University of Amsterdam has found that the drug guanabenz, used to treat high blood pressure, may help slow the progression of leukodystrophy, a rare and serious neurological disorder that affects children between the ages of one and six. The condition causes gradual loss of motor and cognitive abilities and can lead to early death. The results showed that children treated with the medication became less dependent on wheelchairs and showed improvements at a slower rate. The number of deaths during the study also decreased. Some temporary side effects were observed, such as hallucinations and drowsiness, but children tolerated the medication well after months of treatment. The disease is not yet cured, and ongoing studies continue to explore the effects of higher doses to understand the medication’s long-term efficacy. It is important to note that the drug does not provide a final cure but assists in slowing the disease's progression.
Notice: This Is an AI-Generated Summary
Comments (0)